SCHEDULE: Sanjay Gajendra Discloses 4.5% Stake in Astera Labs

Sanjay Gajendra, a U.S. citizen, has reported beneficial ownership of 4.5% of Astera Labs, Inc.'s common stock as of September 30, 2025.

Summary

• Sanjay Gajendra beneficially owns 7,565,234 shares of Astera Labs, Inc. common stock.
• This ownership represents 4.5% of the company's outstanding common stock.
• The total beneficial ownership includes 7,396,213 shares held in estate planning trusts, over which Gajendra has voting and dispositive power.
• Additionally, 169,021 shares are included from restricted stock units (RSUs) that Gajendra has acquired or has the right to acquire through settlement within 60 days of September 30, 2025.
• The percentage of class was calculated based on 168,903,616 shares of Common Stock outstanding as of October 31, 2025, as reported by Astera Labs, Inc. in its Quarterly Report on Form 10-Q filed on November 5, 2025, plus the 169,021 RSU shares deemed outstanding.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of beneficial ownership. It doesn't provide positive or negative operational news, but confirms a significant stake by an individual, likely an insider, which can be viewed neutrally to slightly positive for stability.

Future Outlook

No forward-looking statements or guidance are provided in this beneficial ownership disclosure.

Industry Context

This filing is a routine disclosure of beneficial ownership by an individual, likely an insider, and does not provide specific industry context or trends.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant individual holding, which may indicate continued insider confidence in the company.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership by Sanjay Gajendra, indicating a 4.5% stake in Astera Labs. It primarily updates the public record on an existing holding, including shares in estate planning trusts and RSUs. As such, it does not present new information that would fundamentally alter the investment thesis for Astera Labs, nor does it suggest any immediate catalysts for significant price movement. The filing confirms a substantial insider stake, which can be a neutral to slightly positive signal of long-term commitment, but it lacks operational or financial news to warrant a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive company updates.

Keywords

Astera Labs, Sanjay Gajendra, Schedule 13G, Beneficial Ownership, Common Stock, Equity Stake, SEC Filing, ASTL